https://www.selleckchem.com/pr....oducts/pepstatin-a.h
Together with the potential metabolic targets of DCs, possible anti-tumor therapeutic pathways were summarized.Background Several host inflammatory markers have been proposed as biomarkers for diagnosis and treatment response in Tuberculosis (T, but few studies compare their utility in different demographic, ethnic, and TB endemic settings. Methods Fifty-four host biomarkers were evaluated in plasma samples obtained from presumed TB cases recruited at the Oslo University Hospital in Norway, and a health center in Cape Town, South
Like
Comment
Share
